Fate-Mapping of GM-CSF Expression Identifies a Discrete Subset of Inflammation-Driving T Helper Cells Regulated by Cytokines IL-23 and IL-1β

被引:144
作者
Komuczki, Juliana [1 ]
Tuzlak, Selma [1 ]
Friebel, Ekaterina [1 ]
Hartwig, Tom [1 ]
Spath, Sabine [1 ,9 ]
Rosenstiel, Philip [4 ,5 ]
Waisman, Ari [6 ]
Opitz, Lennart [8 ]
Oukka, Mohammed [7 ]
Schreiner, Bettina [1 ,3 ]
Pelczar, Pawel [2 ]
Becher, Burkhard [1 ]
机构
[1] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland
[2] Univ Basel, Ctr Transgen Models, Basel, Switzerland
[3] Univ Hosp Zurich, Neurol Clin, Zurich, Switzerland
[4] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany
[5] Univ Hosp Schleswig Holstein, Kiel, Germany
[6] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Mainz, Germany
[7] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA
[8] Univ Zurich, Funct Genom Ctr Zurich, ETH Zurich, Zurich, Switzerland
[9] Benaroya Res Inst, Seattle, WA USA
基金
欧盟地平线“2020”; 瑞士国家科学基金会;
关键词
COLONY-STIMULATING FACTOR; COLLAGEN-INDUCED ARTHRITIS; EFFECTOR PHASE; TH17; CELLS; MULTIPLE-SCLEROSIS; FETAL MONOCYTES; T(H)17 CELLS; TGF-BETA; DIFFERENTIATION; RECEPTOR;
D O I
10.1016/j.immuni.2019.04.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pathogenic lymphocytes initiate the development of chronic inflammatory diseases. The cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) (encoded by Csf2) is a key communicator between pathogenic lymphocytes and tissue-invading inflammatory phagocytes. However, the molecular properties of GM-CSF-producing cells and the mode of Csf2 regulation in vivo remain unclear. To systematically study and manipulate GM-CSF+ cells and their progeny in vivo, we generated a fate-map and reporter of GM-CSF expression mouse strain (FROG). We mapped the phenotypic and functional profile of auto-aggressive T helper (Th) cells during neuroinflammation and identified the signature and pathogenic memory of a discrete encephalitogenic Th subset. These cells required interleukin-23 receptor (IL-23R) and IL-1R but not IL-6R signaling for their maintenance and pathogenicity. Specific ablation of this subset interrupted the inflammatory cascade, despite the unperturbed tissue accumulation of other Th subsets (e.g., Th1 and Th17), high-lighting that GM-CSF expression not only marks pathogenic Th cells, but that this subset mediates immunopathology and tissue destruction.
引用
收藏
页码:1289 / +
页数:22
相关论文
共 97 条
[1]   Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation [J].
Aden, Konrad ;
Rehman, Ateequr ;
Falk-Paulsen, Maren ;
Secher, Thomas ;
Kuiper, Jan ;
Tran, Florian ;
Pfeuffer, Steffen ;
Sheibani-Tezerji, Raheleh ;
Breuer, Alexandra ;
Luzius, Anne ;
Jentzsch, Marlene ;
Haesler, Robert ;
Billmann-Born, Susanne ;
Will, Olga ;
Lipinski, Simone ;
Bharti, Richa ;
Adolph, Timon ;
Iovanna, Juan L. ;
Kempster, Sarah L. ;
Blumberg, Richard S. ;
Schreiber, Stefan ;
Becher, Burkhard ;
Chamaillard, Mathias ;
Kaser, Arthur ;
Rosenstiel, Philip .
CELL REPORTS, 2016, 16 (08) :2208-2218
[2]   Inhibition of IL-6 family cytokines by SOCS3 [J].
Babon, Jeffrey J. ;
Varghese, Leila N. ;
Nicola, Nicos A. .
SEMINARS IN IMMUNOLOGY, 2014, 26 (01) :13-19
[3]   Multiple Sclerosis: Mechanisms and Immunotherapy [J].
Baecher-Allan, Clare ;
Kaskow, Belinda J. ;
Weiner, Howard L. .
NEURON, 2018, 97 (04) :742-768
[4]   IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis [J].
Becher, B ;
Durell, BG ;
Noelle, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (08) :1186-1191
[5]   Conditional Gene-Targeting in Mice: Problems and Solutions [J].
Becher, Burkhard ;
Waisman, Ari ;
Lu, Li-Fan .
IMMUNITY, 2018, 48 (05) :835-836
[6]   GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation [J].
Becher, Burkhard ;
Tugues, Sonia ;
Greter, Melanie .
IMMUNITY, 2016, 45 (05) :963-973
[7]   Hiding under the skin Interleukin-17-producing γδT cells go under the skin? [J].
Becher, Burkhard ;
Pantelyushin, Stanislav .
NATURE MEDICINE, 2012, 18 (12) :1748-1750
[8]   TH17 cytokines in autoimmune neuro-inflammation [J].
Becher, Burkhard ;
Segal, Benjamin M. .
CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (06) :707-712
[9]   MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial [J].
Behrens, Frank ;
Tak, Paul P. ;
Ostergaard, Mikkel ;
Stoilov, Rumen ;
Wiland, Piotr ;
Huizinga, Thomas W. ;
Berenfus, Vadym Y. ;
Vladeva, Stoyanka ;
Rech, Juergen ;
Rubbert-Roth, Andrea ;
Korkosz, Mariusz ;
Rekalov, Dmitriy ;
Zupanets, Igor A. ;
Ejbjerg, Bo J. ;
Geiseler, Jens ;
Fresenius, Julia ;
Korolkiewicz, Roman P. ;
Schottelius, Arndt J. ;
Burkhardt, Harald .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) :1058-1064
[10]   Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis [J].
Bettelli, E ;
Pagany, M ;
Weiner, HL ;
Linington, C ;
Sobel, RA ;
Kuchroo, AK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1073-1081